MGH Northshore Cancer Center — Danvers, Massachusetts

MGH Northshore Cancer Center is a clinical research site located in Danvers, Massachusetts, United States 01923.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

MGH Northshore Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Breast Neoplasm, Neoplasm Metastasis.

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MGH Northshore Cancer Center?

MGH Northshore Cancer Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MGH Northshore Cancer Center conducted?

MGH Northshore Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Breast Neoplasm, Neoplasm Metastasis.

Is MGH Northshore Cancer Center accredited by Crixeo Health?

MGH Northshore Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MGH Northshore Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.